* Name:
Address:
City:
State: Select One AL AK AS AZ AR CA CO CT DE DC FM FL GA GU HI ID IL IN IA KS KY LA ME MH MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND MP OH OK OR PW PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY
ZIP Code:
* Phone Number:
Other Phone:
* E-mail Address:
Date of Injury:
Type of Injury: Select Injury Type ---------------------------- Auto Accident Brain Injury Defective Medical Device Defective Product Drug Injuries Environmental Fire and Burn Injury Insurance Dispute Motorcycle Accident Nursing Home Abuse Slip & Fall Social Security Stock Fraud Truck Accident Workers Compensation Wrongful Death Yamaha Rollover Accident ---------------------------- Fentanyl Pain Patch Fixodent Fosamax Hernia Patch Danger MRI Dye (NSF) Proactiv Raptiva Reglan Trasylol Yaz ---------------------------- Other
If "Other," Please Specify:
Work Status Due to the Injury: Able Unable
Medical Treatment: Yes No
Currently in Treatment: Yes No
* Injury Description:
Specific Questions:
Contact Preference: E-mail Phone Mail
Best Time to Call: Select One Morning Daytime Evening
How You Heard About Us: Select One TV Ad Yellow Pages Billboard Internet Search Friend Referral Other
By submitting this form, you understand and agree to the following: your case may be evaluated by an attorney who may contact you about this matter; the submission of your information in no way constitutes an attorney-client relationship; and the use of the information you submit on this site is governed by our Terms and Conditions.
If you experience problems with this page, please contact our webmaster.
Do not discontinue taking any medications without first consulting your physician.Fosamax® use leading to osteonecrosis of the jawFosamax® (alendronate), a drug that has been on the market for almost 10 years, has been linked to osteonecrosis of the jaw (ONJ) (1). Otherwise known as “dead jaw,” osteonecrosis is a severe condition in which the jaw dies and is unable to regenerate, eventually leading to extreme pain and exposed bone in the mouth.Fosamax is an oral drug used in the treatment of osteoporosis (bone loss) in post-menopausal women; to increase bone mass in men with osteoporosis; and to treat Paget’s disease (a lifelong chronic condition that results in abnormal bone growth) (2).Fosamax is part of a class of drugs known as bisphosphonates, which are used to treat osteoporosis and bone pain caused by some types of cancer. Fosamax is the most commonly dispensed bisphosphonate in the United States and reached 22 million prescriptions by 2004 (2). Bisphosphonates are often used in the management of certain cancers—such as lung, breast, prostate, and multiple myeloma—where cancer has metastasized (spread) to the bone.Bisphosphonates, once taken, remain in the bones indefinitely (1). The coauthor of a report on osteonecrosis of the jaw resulting from bisphosphonate use, published in the Journal of Oral and Maxillofacial Surgery, writes that drugs such as Fosamax could upset the delicate balance between the cells that put calcium in bone and the cells that take calcium away (1). His report prompted the Food and Drug Administration (FDA) to post a review saying that osteonecrosis of the jaw is a risk for all bisphosphonates, which includes both oral and intravenous doses.What is osteonecrosis of the jaw?Also known as “dead jaw,” osteonecrosis is the destruction of bone tissue. Osteonecrosis of the jaw is a painful, deteriorative condition that involves soft-tissue swelling in the mouth, infection, loosening of the teeth, drainage, and exposed bone. It is often the result of blood not properly reaching the bone.There are several other bisphosphonate drugs on the market, all of which have been linked to ONJ (1). Actonel® is an oral bisphoshonate drug similar to Fosamax and is manufactured by Procter & Gamble Pharmaceuticals. Aredia® (pamidronate disodium) and Zometa® (zoledronic acid), both manufactured by Novartis, now include labeling on the drugs to include reports of osteonecrosis of the jaw in people who have taken bisphosphonates.Talk to a lawyerOsteonecrosis of the jaw is a painful condition that can result in serious health complications. Contact a Fosamax lawyer at our firm if you have taken any bisphosphonate drugs and later suffered osteonecrosis of the jaw. We will put our considerable resources behind all cases in which pharmaceutical drugs have harmed innocent victims. Call us immediately for a free consultation and speak with a Fosamax lawyer today. We want to help.Sources:1) Drug Link to Death of Jawbone, by Rita Rubin, USA Today. Accessed on 04/14/06 from http://www.usatoday.com/.2) IMS Health, National Prescription AuditPlus, On-Line, May 2001 - April 2004, Data Extracted May 2004. Appears in FDA’s One Year Post Exclusivity Adverse Event Review: Alendronate accessed on 04/14/06.This law firm is not associated with, sponsored by, or affiliated with the Journal of Oral and Maxillofacial Surgery, the Food and Drug Administration, Merck & Co., Inc., Procter & Gamble Pharmaceuticals, Novartis Pharmaceuticals, USA Today, or IMS Health.Fosamax® is a registered trademark of Merck & Co., Inc., and is used here only to identify the product in question. Actonel® is a registered trademark of Procter & Gamble Pharmaceuticals and is used here only to identify the product in question. Aredia® and Zometa® are registered trademarks of Novartis Pharmaceuticals, Inc., and are used here only to identify the products in question.
Do not discontinue taking any medications without first consulting your physician.
Fosamax® use leading to osteonecrosis of the jaw
Fosamax® (alendronate), a drug that has been on the market for almost 10 years, has been linked to osteonecrosis of the jaw (ONJ) (1). Otherwise known as “dead jaw,” osteonecrosis is a severe condition in which the jaw dies and is unable to regenerate, eventually leading to extreme pain and exposed bone in the mouth.
Fosamax is an oral drug used in the treatment of osteoporosis (bone loss) in post-menopausal women; to increase bone mass in men with osteoporosis; and to treat Paget’s disease (a lifelong chronic condition that results in abnormal bone growth) (2).
Fosamax is part of a class of drugs known as bisphosphonates, which are used to treat osteoporosis and bone pain caused by some types of cancer. Fosamax is the most commonly dispensed bisphosphonate in the United States and reached 22 million prescriptions by 2004 (2). Bisphosphonates are often used in the management of certain cancers—such as lung, breast, prostate, and multiple myeloma—where cancer has metastasized (spread) to the bone.
Bisphosphonates, once taken, remain in the bones indefinitely (1). The coauthor of a report on osteonecrosis of the jaw resulting from bisphosphonate use, published in the Journal of Oral and Maxillofacial Surgery, writes that drugs such as Fosamax could upset the delicate balance between the cells that put calcium in bone and the cells that take calcium away (1). His report prompted the Food and Drug Administration (FDA) to post a review saying that osteonecrosis of the jaw is a risk for all bisphosphonates, which includes both oral and intravenous doses.
What is osteonecrosis of the jaw?
Also known as “dead jaw,” osteonecrosis is the destruction of bone tissue. Osteonecrosis of the jaw is a painful, deteriorative condition that involves soft-tissue swelling in the mouth, infection, loosening of the teeth, drainage, and exposed bone. It is often the result of blood not properly reaching the bone.
There are several other bisphosphonate drugs on the market, all of which have been linked to ONJ (1). Actonel® is an oral bisphoshonate drug similar to Fosamax and is manufactured by Procter & Gamble Pharmaceuticals. Aredia® (pamidronate disodium) and Zometa® (zoledronic acid), both manufactured by Novartis, now include labeling on the drugs to include reports of osteonecrosis of the jaw in people who have taken bisphosphonates.
Talk to a lawyer
Osteonecrosis of the jaw is a painful condition that can result in serious health complications. Contact a Fosamax lawyer at our firm if you have taken any bisphosphonate drugs and later suffered osteonecrosis of the jaw. We will put our considerable resources behind all cases in which pharmaceutical drugs have harmed innocent victims. Call us immediately for a free consultation and speak with a Fosamax lawyer today. We want to help.
Sources:
1) Drug Link to Death of Jawbone, by Rita Rubin, USA Today. Accessed on 04/14/06 from http://www.usatoday.com/.
2) IMS Health, National Prescription AuditPlus, On-Line, May 2001 - April 2004, Data Extracted May 2004. Appears in FDA’s One Year Post Exclusivity Adverse Event Review: Alendronate accessed on 04/14/06.
This law firm is not associated with, sponsored by, or affiliated with the Journal of Oral and Maxillofacial Surgery, the Food and Drug Administration, Merck & Co., Inc., Procter & Gamble Pharmaceuticals, Novartis Pharmaceuticals, USA Today, or IMS Health.
Fosamax® is a registered trademark of Merck & Co., Inc., and is used here only to identify the product in question. Actonel® is a registered trademark of Procter & Gamble Pharmaceuticals and is used here only to identify the product in question. Aredia® and Zometa® are registered trademarks of Novartis Pharmaceuticals, Inc., and are used here only to identify the products in question.
*Cases likely to be referred
Have you or someone you care about received a fosamax injury? Contact a Hughes & Coleman drug injury lawyer today. We have offices in Bowling Green, Louisville, Lexington, Murfreesboro, Nashville, Gallatin, and Clarksville. Complete a FREE Consultation Form online or call us today.
Your Questions
